Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SMMT | UTHR | NBIX | ||
| Company | Summit Therapeu ADR | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 17.65 | 475.59 | 135.24 | ||
| High | 17.86 | 476.45 | 135.98 | ||
| Low | 17.21 | 467.68 | 131.30 | ||
| Latest | 17.27 | 471.99 | 133.35 | ||
| Change | -0.38 | -3.74 | -1.98 | ||
| % Change | -2.15% | -0.79% | -1.46% | ||
| Volume | 2,673,400 | 292,300 | 890,900 | ||
| 20-Day Average Volume | 2,673,085 | 441,450 | 1,156,680 | ||
| Previous Close | 17.65 | 475.73 | 135.33 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.87 | 497.06 | 140.07 | ||
| 20-Day Raw Stochastic | 25.45% | 8.24% | 10.69% | ||
| 20-Day Relative Strength | 46.12 | 44.48 | 39.15 | ||
| Weighted Alpha | -9.70 | +29.99 | -3.29 | ||
| Today's Opinion | 80% Sell | 56% Buy | 8% Sell | ||
| Previous Opinion | 80% Sell | 56% Buy | 8% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.28% since 01/08/26 | -3.84% since 01/08/26 | -1.64% since 01/08/26 | ||
| Low | 16.27 on 01/13/26 | 467.68 on 01/15/26 | 131.30 on 01/15/26 | ||
| High | 20.20 on 01/09/26 | 493.27 on 01/09/26 | 137.07 on 01/09/26 | ||
| 1-Month | |||||
| %Chg | -0.63% since 12/15/25 | -5.66% since 12/15/25 | -13.44% since 12/15/25 | ||
| Low | 16.27 on 01/13/26 | 467.68 on 01/15/26 | 131.30 on 01/15/26 | ||
| High | 20.20 on 01/09/26 | 519.99 on 12/23/25 | 155.23 on 12/16/25 | ||
| 3-Month | |||||
| %Chg | -23.72% since 10/15/25 | +9.21% since 10/15/25 | -3.18% since 10/15/25 | ||
| Low | 15.62 on 11/21/25 | 409.07 on 10/28/25 | 131.30 on 01/15/26 | ||
| High | 23.61 on 10/16/25 | 519.99 on 12/23/25 | 160.18 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | -29.11% since 07/15/25 | +60.96% since 07/15/25 | +1.61% since 07/15/25 | ||
| Low | 15.62 on 11/21/25 | 272.12 on 07/31/25 | 123.67 on 08/08/25 | ||
| High | 30.98 on 08/05/25 | 519.99 on 12/23/25 | 160.18 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,610,798 | 20,483,502 | 13,493,214 | ||
| Shares Outstanding, K | 771,150 | 43,057 | 99,706 | ||
| Annual Sales | 0 | 2,877,400,000 | 2,355,300,000 | ||
| Annual Net Income | -221,320,000 | 1,195,100,000 | 341,300,000 | ||
| Last Quarter Sales | 0 | 799,500,000 | 794,900,000 | ||
| Last Quarter Net Income | -231,790,000 | 338,700,000 | 209,500,000 | ||
| 60-Month Beta | -1.51 | 0.84 | 0.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 10/20/25 | 7.16 on 10/29/25 | 2.04 on 10/28/25 | ||
| Latest Earnings Date | 02/23/26 | 02/25/26 | 02/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.07 | 31.64 | ||